The cost-utility analysis of PET-scan in diagnosis and treatment of non-small cell lung carcinoma in Iran

Iranian Journal of Radiology

Volumn 10, Issue 2, 2013, Pages

  Sari, Ali Akbari ^a   Ravaghi, Hamid ^b   Mobinizadeh, Mohammadreza ^c   Sarvari, Sima ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Economics; Non small cell lung carcinoma; Positron emission tomography

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BUILDING; CANCER RADIOTHERAPY; COST UTILITY ANALYSIS; DRUG COST; ECONOMIC EVALUATION; EQUIPMENT; EQUIPMENT MAINTENANCE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; IRAN; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MEDIASTINOSCOPY; MEDICAL DECISION MAKING; POSITRON EMISSION TOMOGRAPHY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 84878323180     PISSN: 17351065     EISSN: 20082711     Source Type: Journal    
DOI: 10.5812/iranjradiol.8559     Document Type: Article

References (10)

1. Bridges JF, Jones C. Patient-based health technology assess-ment: a vision of the future. Int J Technol Assess Health Care. 2007;23(1):30-5
2. Lung Cancer - Non-Small Cell. Available from: http://www.cancer.org/cancer/lungcancer-non-smallcell/index.
3. Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in se-lected cancers. Health Technol Assess. 2007;11(44):iii-iv
4. Ravaghi H, Akbari Sari A, Sarvari S, Mobinizadeh MR. The Effec-tiveness of PET-Scan in Diagnosis and Treatment of Non-Small Cell Lung Carcinoma (NSCLC) and Lymphoma: A Comprehensive Review of Literature. J Isfahan Med School. 2012;29(167)
5. Positron emission tomography. 2001; Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/8FD1D98FE64C8A2FCA2575AD0082FD8F/$File/Ref%2010%20part%202ii%20-%20PET%20Report.pdf.
6. Drummond MF, Sculpher MJ, Torrance GW. Methods for the Eco-nomic Evaluation of Health Care Programs. 2005.
7. Akers J. Systematic Reviews: CRD's Guidance for Undertaking Re-views in Health Care. 2009.
8. Abbasi A, Adhami S, Javaherzadeh M, Daneshvar Kakhi A, Pejhan S, Arab M, et al. Role of operation in lung cancer. Sci J Kurd Univ Med Sci. 2004;31:59-67
9. Positron emission tomography (PET) imaging in cancer manage-ment; HTA Advice 2: Positron emission tomography (PET) imag-ing in cancer management; Understanding HTBS Advice; Use of PET imaging for cancer in Scotland. Amendment to full report. 2005; Available from: http://www.crd.york.ac.uk/CRDWeb/Show-Record.asp?View=Full&ID=32003000095.
10. Price P, Laking G. How should we introduce clinical PET in the UK? The oncologists need to have a view. Clin Oncol (R Coll Radiol). 2004;16(3):172-5